WASHINGTON — A key Senate Republican renewed his commitment to ramping up oversight of a controversial drug discount program in a hearing Tuesday.
Sen. Lamar Alexander of Tennessee, who chairs the Senate health committee, called for stricter reporting requirements and a closer examination of participants in the so-called 340B program, under which drug makers must give eligible hospitals discounts on their medicines. The hearing was his panel’s third examination of the program.
“It seems to me that it would be helpful for us to know how hospitals and clinics spend the money they save from discounted drug prices. Why shouldn’t we require that hospitals and clinics tell us how they’re using their 340B savings so that we can know how the money is spent?” he asked.